Paper Details

  1. Home
  2. Paper Details

Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options.

Author: ShahEric D, WechslerEmily V

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This review summarizes the clinical profiles of efficacy, safety, and tolerability of prescription drugs for irritable bowel syndrome (IBS), including cost-effectiveness of drugs for diarrhea-predominant IBS and constipation-predominant IBS.
Paper Details　
Original Abstract of the Article :
Irritable bowel syndrome (IBS) is a heterogenous disease with a variety of therapeutic options, including eight prescription drugs approved for use in IBS in the USA. Choosing among the myriad treatment options requires attention to patient preferences both on clinical outcomes and costs associated ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s40265-021-01634-7

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of IBS: A Guide to Prescription Drugs

Irritable bowel syndrome (IBS) is a common and often frustrating condition, like a desert with unpredictable weather. This research provides a comprehensive guide to the prescription drugs available for treating IBS in the USA. The study focuses on the different types of IBS, diarrhea-predominant (IBS-D) and constipation-predominant (IBS-C), and examines the efficacy, safety, tolerability, and cost-effectiveness of various prescription drugs. The researchers emphasize the importance of shared decision-making between patients and doctors to choose the most appropriate treatment option.

A Guide to the Desert of IBS Medications

This research offers a practical and insightful guide to the different prescription drugs available for treating IBS. By providing a comprehensive overview of the efficacy, safety, and cost-effectiveness of these medications, it empowers patients and doctors to make informed decisions about treatment options. It's like having a detailed map of the desert of IBS medications, guiding patients towards the most suitable treatment path.

Finding Relief in the Desert of IBS

IBS can be a challenging condition, but this research offers hope for finding relief. By providing a detailed comparison of available prescription drugs, the study helps patients and doctors navigate the complexities of treatment options. It's like finding a refreshing oasis in the desert of IBS, offering a chance for improved symptoms and a better quality of life.

Dr. Camel's Conclusion

This research is a valuable resource for patients and healthcare providers seeking information about IBS treatment options. By providing a comprehensive overview of available medications, the study helps patients and doctors make informed decisions about treatment, leading to better outcomes and a more comfortable journey through the desert of IBS.

Date :
  1. Date Completed 2022-02-14
  2. Date Revised 2022-02-14
Further Info :

Pubmed ID

34727333

DOI: Digital Object Identifier

10.1007/s40265-021-01634-7

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.